Showing results (101-110 of 125) with videos related to
Sort By:
Pageof 13
Cellular Immunology|August 25, 1996
Recognition and lysis of human melanoma by a CD3+, CD4+, CD8- T-cell clone restricted by HLA-A2T L Darrow, Z Abdel-Wahab, M A Quinn-Allen, et al.Cellular Immunology|February 1, 1990
Modulation of in vitro autologous melanoma-specific cytotoxic T-cell responses by phorbol dibutyrate and ionomycinT L Darrow, M A Quinn-Allen, N J Crowley, et al.Journal of Immunology (Baltimore, Md. : 1950)|March 1, 1991
MHC-restricted recognition of autologous melanoma by tumor-specific cytotoxic T cells. Evidence for restriction by a dominant HLA-A alleleN J Crowley, T L Darrow, M A Quinn-Allen, et al.Journal of the National Cancer Institute|September 7, 1988
Human cytotoxic T cells specific for autologous melanoma cells: successful generation from lymph node cells in seven consecutive casesC L Slingluff, T Darrow, C Vervaert, et al.The Journal of Biological Chemistry|August 24, 2011
Modulation of prothrombinase assembly and activity by phosphatidylethanolamineRinku Majumder, Xiaoe Liang, Mary Ann Quinn-Allen, et al.Biochemistry|April 7, 2004
Trp2063 and Trp2064 in the factor Va C2 domain are required for high-affinity binding to phospholipid membranes but not for assembly of the prothrombinase complexWeimin Peng, Mary Ann Quinn-Allen, Suhng Wook Kim, et al.Biochemistry|July 11, 2001
Soluble phosphatidylserine binds to a single identified site in the C2 domain of human factor VaA Srivastava, M A Quinn-Allen, S W Kim, et al.The Biochemical Journal|January 29, 2014
Phosphatidylserine and FVa regulate FXa structureKinshuk Raj Srivasatava, Rinku Majumder, William H Kane, et al.The Journal of Clinical Investigation|December 1, 1992
Characterization of an acquired inhibitor to coagulation factor V. Antibody binding to the second C-type domain of factor V inhibits the binding of factor V to phosphatidylserine and neutralizes procoagulant activityT L Ortel, M A Quinn-Allen, L A Charles, et al.Thrombosis Research|May 3, 2008
Location of the multimerin 1 binding site in coagulation factor V: an updateSamira B Jeimy, Mary Ann Quinn-Allen, Nola Fuller, et al.Pageof 13